Skip to main content
SpringerLink
Log in

Drug-Resistant Tuberculosis

  • Chapter
  • First Online:
Drug Resistance in Bacteria, Fungi, Malaria, and Cancer

  • 1538 Accesses

Abstract

The incidence of drug-resistant tuberculosis (TB), particularly multidrug-resistant TB and extensively drug-resistant TB, is increasing and is a major complication in global attempts to control TB. New anti-TB drugs and rapid diagnostics have been developed; however, the pathogenesis of drug resistance remains unclear. Fragmented treatment regimens, efflux pumps, and pharmacokinetic variability may all play a part in the rise of drug-resistant pathogens. Drug-resistant TB continues to be associated with poor treatment outcomes and high mortality rates.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agarwal A, Dhole TN, Sharma YK (2014) Evaluation of p-nitro benzoic acid (pnb) inhibition test to differentiate Mycobacterium tuberculosis complex from non-tuberculous mycobacteria using microscopic observation of drug susceptibility (MODS) methodology. Indian J Tuberc 61:232–235

    CAS  PubMed  Google Scholar 

  • Aubry A, Sougakoff W, Bodzongo P, Delcroix G, Armand S, Millot G, Jarlier V, Courcol R, Lemaitre N (2014) First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA. PLoS One 9, e95083. doi:10.1371/journal.pone.0095083

    Article  PubMed  PubMed Central  Google Scholar 

  • Basile JI, Geffner LJ, Romero MM, Balboa L, Sabio YGC, Ritacco V, Garcia A, Cuffre M, Abbate E, Lopez B, Barrera L, Ambroggi M, Aleman M, Sasiain MC, de la Barrera SS (2011) Outbreaks of mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load. J Infect Dis 204:1054–1064. doi:10.1093/infdis/jir460

    Article  CAS  PubMed  Google Scholar 

  • Biadglegne F, Mulu A, Rodloff AC, Sack U (2014) Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia. Tuberculosis (Edinb) 94:502–505. doi:10.1016/j.tube.2014.05.002

    Article  CAS  Google Scholar 

  • Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O’Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA (2003) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167:603–662. doi:10.1164/rccm.167.4.603

    Article  PubMed  Google Scholar 

  • Borrell S, Gagneux S (2009) Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13:1456–1466

    CAS  PubMed  Google Scholar 

  • Branscheid D, Albrecht CM, Diemel KD (2003) Surgical therapy of pulmonary tuberculosis. Internist (Berl) 44:1406–1412. doi:10.1007/s00108-003-1074-6

    Article  CAS  Google Scholar 

  • Butov DA, Efremenko YV, Prihoda ND, Yurchenko LI, Sokolenko NI, Arjanova OV, Stepanenko AL, Butova TS, Zaitzeva SS, Jirathitikal V, Bourinbaiar AS, Kutsyna GA (2012) Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV. Immunotherapy 4:687–695. doi:10.2217/imt.12.59

    Article  CAS  PubMed  Google Scholar 

  • Calligaro GL, Moodley L, Symons G, Dheda K (2014) The medical and surgical treatment of drug-resistant tuberculosis. J Thorac Dis 6:186–195. doi:10.3978/j.issn.2072-1439.2013.11.11

    PubMed  PubMed Central  Google Scholar 

  • Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, Hanekom M, Liversage T, Masibi M, van Helden PD, Warren RM, Victor TC (2010) Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis 16:264–271. doi:10.3201/eid02l0.090968

    Article  PubMed  PubMed Central  Google Scholar 

  • Casali N, Nikolayevskyy V, Balabanova Y, Ignatyeva O, Kontsevaya I, Harris SR, Bentley SD, Parkhill J, Nejentsev S, Hoffner SE, Horstmann RD, Brown T, Drobniewski F (2012) Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res 22:735–745. doi:10.1101/gr.128678.111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Causse M, Ruiz P, Gutierrez-Aroca JB, Casal M (2011) Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis. J Clin Microbiol 49:3065–3067. doi:10.1128/JCM.00491-11

    Article  PubMed  PubMed Central  Google Scholar 

  • Chisti MJ, Ahmed T, Pietroni MA, Faruque AS, Ashraf H, Bardhan PK, Hossain I, Das SK, Salam MA (2013) Pulmonary tuberculosis in severely-malnourished or HIV-infected children with pneumonia: a review. J Health Popul Nutr 31:308–313

    PubMed  PubMed Central  Google Scholar 

  • Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M, Galagan J, Niemann S, Gagneux S (2012) Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 44:106–110. doi:10.1038/ng.1038

    Article  CAS  Google Scholar 

  • Crudu V, Stratan E, Romancenco E, Allerheiligen V, Hillemann A, Moraru N (2012) First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J Clin Microbiol 50:1264–1269. doi:10.1128/JCM.05903-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cummings I, O’Grady J, Pai V, Kolvekar S, Zumla A (2012) Surgery and tuberculosis. Curr Opin Pulm Med 18:241–245. doi:10.1097/MCP.0b013e3283521391

    Article  PubMed  Google Scholar 

  • Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C (2010a) Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 375:1798–1807. doi:10.1016/S0140-6736(10)60492-8

    Article  PubMed  Google Scholar 

  • Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y (2010b) The immunology of tuberculosis: from bench to bedside. Respirology 15:433–450. doi:10.1111/j.1440-1843.2010.01739.x

    Article  PubMed  Google Scholar 

  • Dlugovitzky D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J (2006) Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis. Respir Med 100:1079–1087. doi:10.1016/j.rmed.2005.09.026

    Article  PubMed  Google Scholar 

  • Dye C, Williams BG, Espinal MA, Raviglione MC (2002) Erasing the world’s slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295:2042–2046. doi:10.1126/science.1063814

    Article  CAS  PubMed  Google Scholar 

  • Eum SY, Lee YJ, Min JH, Kwak HK, Hong MS, Kong JH, Hwang SH, Park SK, Leblanc JJ, Via LE, Barry CE, Cho SN (2010) Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis. Respiration 80:275–284. doi:10.1159/000283687

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Faujdar J, Gupta P, Natrajan M, Das R, Chauhan DS, Katoch VM, Gupta UD (2011) Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis. Indian J Med Res 134:696–703. doi:10.4103/0971-5916.90999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM (2013) Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet 45:784–790. doi:10.1038/ng.2656

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gao XF, Yang ZW, Li J (2011) Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. Int J Infect Dis 15:e594–e600. doi:10.1016/j.ijid.2011.05.00

    Article  CAS  PubMed  Google Scholar 

  • Guglielmetti L, Du DL, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Metivier N, Robert J (2015) Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort. Clin Infect Dis 60:188–194. doi:10.1093/cid/ciu786

    Article  CAS  PubMed  Google Scholar 

  • Gumbo T (2013) Biological variability and the emergence of multidrug-resistant tuberculosis. Nat Genet 45:720–721. doi:10.1038/ng.2675

    Article  CAS  PubMed  Google Scholar 

  • Gumbo T, Louie A, Deziel MR, Parsons LM, Salfinger M, Drusano GL (2004) Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. J Infect Dis 190:1642–1651. doi:10.1086/424849

    Article  CAS  PubMed  Google Scholar 

  • Gumbo T, Louie A, Deziel MR, Drusano GL (2005) Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance. Antimicrob Agents Chemother 49:3178–3181. doi:10.1128/AAC.49.8.3178-3181.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gumbo T, Louie A, Deziel MR, Liu W, Parsons LM, Salfinger M, Drusano GL (2007a) Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin. Antimicrob Agents Chemother 51:3781–3788. doi:10.1128/AAC.01533-06

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gumbo T, Louie A, Liu W, Ambrose PG, Bhavnani SM, Brown D, Drusano GL (2007b) Isoniazid’s bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. J Infect Dis 195:194–201. doi:10.1086/510247

    Article  CAS  PubMed  Google Scholar 

  • Gumbo T, Dona CS, Meek C, Leff R (2009) Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs. Antimicrob Agents Chemother 53:3197–3204. doi:10.1128/AAC.01681-08

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gupta A, Ahmad FJ, Ahmad F, Gupta UD, Natarajan M, Katoch VM, Bhaskar S (2012a) Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung. PLoS One 7, e39215. doi:10.1371/journal.pone.0039215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gupta A, Ahmad FJ, Ahmad F, Gupta UD, Natarajan M, Katoch VM, Bhaskar S (2012b) Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model. Vaccine 30:6198–6209. doi:10.1016/j.vaccine.2012.07.061

    Article  CAS  PubMed  Google Scholar 

  • Hillemann D, Rusch-Gerdes S, Boehme C, Richter E (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 49:1202–1205. doi:10.1128/JCM.02268-10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hood ML (2013) A narrative review of recent progress in understanding the relationship between tuberculosis and protein energy malnutrition. Eur J Clin Nutr 67:1122–1128. doi:10.1038/ejcn.2013.143

    Article  CAS  PubMed  Google Scholar 

  • Huang ZK, Luo Q, Jiang BX, Li WT, Xu XM, Xiong GL, Li JM (2013) Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis. Chin Med J (Engl) 126:4334–4339

    Google Scholar 

  • Ioerger TR, Feng Y, Chen X, Dobos KM, Victor TC, Streicher EM, Warren RM, Gey van Pittius NC, Van Helden PD, Sacchettini JC (2010) The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11:670. doi:10.1186/1471-2164-11-670

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacobson KR, Tierney DB, Jeon CY, Mitnick CD, Murray MB (2010) Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 51:6–14. doi:10.1086/653115

    Article  PubMed  PubMed Central  Google Scholar 

  • Jayaram R, Shandil RK, Gaonkar S, Kaur P, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Kantharaj E, Balasubramanian V (2004) Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother 48:2951–2957. doi:10.1128/AAC.48.8.2951-2957.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiang X, Zhang W, Zhang Y, Gao F, Lu C, Zhang X, Wang H (2008) Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb Drug Resist 14:7–11. doi:10.1089/mdr.2008.0772

    Article  CAS  PubMed  Google Scholar 

  • Kang YA, Choi YJ, Cho YJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ (2006) Cost of treatment for multidrug-resistant tuberculosis in South Korea. Respirology 11:793–798. doi:10.1111/j.1440-1843.2006.00948.x

    Article  PubMed  Google Scholar 

  • Kvasnovsky CL, Cegielski JP, Erasmus R, Siwisa NO, Thomas K, Der Walt ML (2011) Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients. J Acquir Immune Defic Syndr 57:146–152. doi:10.1097/QAI.0b013e31821190a3

    Article  PubMed  Google Scholar 

  • Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE (2012) Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 367:1508–1518. doi:10.1056/NEJMoa1201964

    Article  CAS  PubMed  Google Scholar 

  • Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ (2013) The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 138(2):105–115. doi:10.1111/imm.12036

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luria SE, Delbruck M (1943) Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491–511

    CAS  PubMed  PubMed Central  Google Scholar 

  • Marrone MT, Venkataramanan V, Goodman M, Hill AC, Jereb JA, Mase SR (2013) Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 17:6–16. doi:10.5588/ijtld.12.0198

    Article  CAS  PubMed  Google Scholar 

  • Martin A, Cubillos-Ruiz A, Von Groll A, Portillo PD, Portaels F, Palomino JC (2008) Nitrate reductase assay for the rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide. J Antimicrob Chemother 61:123–127. doi:10.1093/jac/dkm418

    Article  CAS  PubMed  Google Scholar 

  • Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA (2012) Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med 9, e1001347. doi:10.1371/journal.pmed.1001347

    Article  PubMed  PubMed Central  Google Scholar 

  • Mordant P, Henry B, Morel S, Robert J, Veziris N, Du DL, Frechet-Jachym M, Similowski T, Caumes E, Riquet M, Pimpec-Barthes FL (2014) Adjuvant surgical resection for multidrug-resistant tuberculosis: a review. Rev Mal Respir 31:511–524. doi:10.1016/j.rmr.2014.01.014

    Article  CAS  PubMed  Google Scholar 

  • Park JS, Lee JY, Lee YJ, Kim SJ, Cho YJ, Yoon HI, Lee CT, Song J, Lee JH (2015) Serum levels of anti-tuberculosis drugs and their effect on tuberculosis treatment outcome. Antimicrob Agents Chemother. doi:10.1128/AAC.00693-15

  • Pasipanodya JG, Gumbo T (2011) A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs. Curr Opin Pharmacol 11:457–463. doi:10.1016/j.coph.2011.07.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pasipanodya JG, Srivastava S, Gumbo T (2012) Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy. Clin Infect Dis 55:169–177. doi:10.1093/cid/cis353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pasipanodya JG, McIlleron H, Burger A, Wash PA, Smith P, Gumbo T (2013) Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis 208:1464–1473. doi:10.1093/infdis/jit352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pooran A, Pieterson E, Davids M, Theron G, Dheda K (2013) What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One 8, e54587. doi:10.1371/journal.pone.0054587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raveendran R, Wattal C, Oberoi JK, Goel N, Datta S, Prasad KJ (2012) Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India. Indian J Med Microbiol 30:58–63. doi:10.4103/0255-0857.93034

    Article  CAS  PubMed  Google Scholar 

  • Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ (2014) Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Lancet Respir Med 2:108–122. doi:10.1016/S2213-2600(13)70234-0

    Article  PubMed  Google Scholar 

  • Spies FS, Da Silva PE, Ribeiro MO, Rossetti ML, Zaha A (2008) Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 52:2947–2949. doi:10.1128/AAC.01570-07

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Srivastava S, Musuka S, Sherman C, Meek C, Leff R, Gumbo T (2010) Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J Infect Dis 201:1225–1231. doi:10.1086/651377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Suarez-Garcia I, Noguerado A (2012) Drug treatment of multidrug-resistant osteoarticular tuberculosis: a systematic literature review. Int J Infect Dis 16:e774–e778. doi:10.1016/j.ijid.2012.07.011

    Article  CAS  PubMed  Google Scholar 

  • Subramanyam B, Sivaramakrishnan G, Dusthackeer A, Kumar V (2013) Phage lysin to control the overgrowth of normal flora in processed sputum samples for the rapid and sensitive detection of Mycobacterium tuberculosis by luciferase reporter phage assay. BMC Infect Dis 13:44. doi:10.1186/1471-2334-13-44

    Article  PubMed  PubMed Central  Google Scholar 

  • Sun G, Luo T, Yang C, Dong X, Li J, Zhu Y, Zheng H, Tian W, Wang S, Barry CE, Mei J, Gao Q (2012) Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J Infect Dis 206:1724–1733. doi:10.1093/infdis/jis601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184:132–140. doi:10.1164/rccm.201101-0056OC

    Article  PubMed  Google Scholar 

  • Tiemersma EW, Van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ (2011) Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One 6, e17601. doi:10.1371/journal.pone.0017601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C (2011) Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 49:2540–2545. doi:10.1128/JCM.02319-10

    Article  PubMed  PubMed Central  Google Scholar 

  • van Kampen SC, Anthony RM, Klatser PR (2010) The realistic performance achievable with mycobacterial automated culture systems in high and low prevalence settings. BMC Infect Dis 10:93. doi:10.1186/1471-2334-10-93

    Article  PubMed  PubMed Central  Google Scholar 

  • Vernon A, Burman W, Benator D, Khan A, Bozeman L (1999) Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet 353:1843–1847. doi:10.1016/S0140-6736(98)11467-8

    Article  CAS  PubMed  Google Scholar 

  • Visalakshi P, Meharwal SK, Myneedu VP, Behera D (2010) Evaluation of direct method of drug susceptibility testing of Mycobacterium tuberculosis to rifampicin and isoniazid by nitrate reductase assay in a national reference laboratory. Diagn Microbiol Infect Dis 66:148–152. doi:10.1016/j.diagmicrobio.2009.09.008

    Article  CAS  PubMed  Google Scholar 

  • Wang M, Guan X, Chi Y, Robinson N, Liu JP (2015) Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): a systematic review of randomised clinical trials. Tuberculosis (Edinb) 95:364–372. doi:10.1016/j.tube.2015.03.003

    Article  Google Scholar 

  • Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, Hodge T (2005) Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin Infect Dis 40:1481–1491. doi:10.1086/429321

    Article  CAS  PubMed  Google Scholar 

  • Weyant MJ, Mitchell JD (2012) Multidrug-resistant pulmonary tuberculosis: surgical challenges. Thorac Surg Clin 22:271–276. doi:10.1016/j.thorsurg.2012.04.003

    Article  PubMed  Google Scholar 

  • WHO (2011) Guidelines approved by the guidelines review committee. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 Update. World Health Organization, Geneva

    Google Scholar 

  • World Health Organization (2013) Definitions and reporting framework for tuberculosis. http://www.who.int/tb/publications/definitions/en/

  • WHO (2014) Guidelines approved by the guidelines review committee. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, Geneva

    Google Scholar 

  • Worley MV, Estrada SJ (2014) Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis. Pharmacotherapy 34(11):1187–1197. doi:10.1002/phar.1482

    Article  CAS  PubMed  Google Scholar 

  • Yang XY, Chen QF, Li YP, Wu SM (2011) Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis. PLoS One 6, e23826. doi:10.1371/journal.pone.0023826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang SH, Zhan P, Sun M, Zhang YP, Ma NL (2012) Perfusing chemotherapy by percutaneous lung puncture in the treatment of extensive drug resistant pulmonary tuberculosis. J Thorac Dis 4:624–628. doi:10.3978/j.issn.2072-1439.2012.06.09

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Henan Provincial Chest Hospital, 1st Weiwu Road, Zhengzhou, 450000, China

    Lili Liang, Xin liu & Yamin Lv

  2. Henan Provincial People’s Hospital, Zhengzhou, China

    Yun Ma

Authors
  1. Lili Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yun Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yamin Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lili Liang .

Editor information

Editors and Affiliations

  1. CSIR - Institute of Genomics and Integrative Biology, Delhi, India

    Gunjan Arora

  2. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

    Andaleeb Sajid

  3. CSIR - Institute of Genomics and Integrative Biology, Delhi, India

    Vipin Chandra Kalia

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Liang, L., Ma, Y., liu, X., Lv, Y. (2017). Drug-Resistant Tuberculosis. In: Arora, G., Sajid, A., Kalia, V. (eds) Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48683-3_8

Download citation

Publish with us

Policies and ethics

Search

Navigation